Evaluation of NF-κB as a Novel Serum Biomarker in Androgenetic Alopecia Patients: A Case-Control Study
July 2025
in “
Arab Board Medical Journal
”
Studysummary This study found that patients with androgenetic alopecia had significantly higher serum NF-κB levels compared to controls, and these levels correlated with disease severity, suggesting NF-κB as a potential biomarker and therapeutic target.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on journals.lww.com →